Invention Grant
- Patent Title: CKIT antibody drug conjugates
-
Application No.: US15329818Application Date: 2015-07-27
-
Publication No.: US10786578B2Publication Date: 2020-09-29
- Inventor: Tinya Abrams , Steven Bruce Cohen , Dylan Daniel , Catrin Finner , Bernhard Hubert Geierstanger , Thomas Huber , William Mallet , Matthew John Meyer , Weijia Ou , Siew Ho Schleyer , Kathrin Ulrike Tissot-Daguette
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Genomics Institute of the Novartis Research Foundation
- Agent Kun Wang
- International Application: PCT/IB2015/055678 WO 20150727
- International Announcement: WO2016/020791 WO 20160211
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K47/68 ; C07K16/28 ; A61K51/10 ; A61K49/00 ; A61P35/02 ; A61K39/395
Abstract:
The present invention relates to anti-cKIT antibodies, antibody fragments, antibody drug conjugates, and their uses for the treatment of cancer.
Public/Granted literature
- US20180193475A1 CKIT ANTIBODY DRUG CONJUGATES Public/Granted day:2018-07-12
Information query
